Comparison of the ocular distribution of a model oligonucleotide after topical instillation in rabbits of conventional and new dosage forms

被引:29
作者
Bochot, A
Mashhour, B
Puisieux, F
Couvreur, P
Fattal, E
机构
[1] Fac Pharm Chatenay Malabry, Lab Physicochim Pharmacotech Biopharm, CNRS, URA 1218, F-92296 Chatenay Malabry, France
[2] Hop Hotel Dieu, Serv Ophtalmol, F-75181 Paris, France
关键词
liposomes; ophthalmic administration; ocular drug distribution; oligonucleotide; poloxamer; 407;
D O I
10.3109/10611869808996838
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The distribution of a model 16-mer oligothymidylate (pdT16) in several ocular tissues (cornea. conjunctiva. scleral iris, lens, aqueous and vitreous humors) was determined after instillation in the eye of various dosage forms in a rabbit model. Radiolabelled pdT16 was applied as a simple solution. a 27% poloxamer 407 gel. a suspension of liposomes or liposomes dispersed within a 27% poloxamer 407 gel. pdT16 concentrations were measured in the tissues and fluids by radioactivity counting at time intervals of 10 min, 2 h and 24 h. When the pdT16 solution was used. the highest concentrations were observed in the conjunctiva and the cornea. while a substantial amount of drug was also present in the sclera. Low concentrations were measured in the iris. Using the same treatment protocol, the two liposomal formulations (liposomes suspension or liposomes dispersed within the poloxamer gel) delivered lon amounts of pdT16 to all ocular tissues, and particularly to the conjunctiva and the cornea. The poloxamer gel provided higher tissue concentrations of pdT16 than liposomes but lower than those observed with the solution except 10 min after administration in the iris where the amounts of pdT16 were higher when administered under the gel form. These findings indicate that liposomal forms may not be considered useful delivery systems for topical administration of oligonucleotides in superficial ocular diseases.
引用
收藏
页码:309 / 313
页数:5
相关论文
共 17 条
[1]   In-vivo studies on dexamethasone sodium phosphate liposomes [J].
AlMuhammed, J ;
Ozer, AY ;
Ercan, MT ;
Hincal, AA .
JOURNAL OF MICROENCAPSULATION, 1996, 13 (03) :293-305
[2]   TEAR-INDUCED RELEASE OF LIPOSOME-ENTRAPPED AGENTS [J].
BARBER, RF ;
SHEK, PN .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 60 (03) :219-227
[3]   Liposomes dispersed within a thermosensitive gel: A new dosage form for ocular delivery of oligonucleotides [J].
Bochot, A ;
Fattal, E ;
Gulik, A ;
Couarraze, G ;
Couvreur, P .
PHARMACEUTICAL RESEARCH, 1998, 15 (09) :1364-1369
[4]   Characterization of a new ocular delivery system based on a dispersion of liposomes in a thermosensitive gel [J].
Bochot, A ;
Fattal, E ;
Grossiord, JL ;
Puisieux, F ;
Couvreur, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 162 (1-2) :119-127
[5]   PENETRATION ROUTES OF TOPICALLY APPLIED EYE MEDICATIONS [J].
DOANE, MG ;
JENSEN, AD ;
DOHLMAN, CH .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1978, 85 (03) :383-386
[6]  
Eder P S, 1991, Antisense Res Dev, V1, P141
[7]   A GAMMA-SCINTIGRAPHIC EVALUATION OF THE PRECORNEAL RESIDENCE OF LIPOSOMAL FORMULATIONS IN THE RABBIT [J].
FITZGERALD, P ;
HADGRAFT, J ;
WILSON, CG .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1987, 39 (06) :487-490
[8]  
Hamalainen KM, 1997, INVEST OPHTH VIS SCI, V38, P627
[9]  
HANNA C, 1980, LIFE SCI, P2509
[10]  
HUANG AJW, 1989, INVEST OPHTH VIS SCI, V30, P684